Cheyne Capital Management (UK) LLP - ONCOGENEX PHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 55 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of ONCOGENEX PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2015$137,000
-53.6%
62,000
-50.8%
0.06%
-32.6%
Q2 2015$295,000
-8.1%
125,892
-16.1%
0.10%
+23.4%
Q1 2015$321,000
-5.0%
150,0000.0%0.08%
-13.5%
Q4 2014$338,000–150,000–0.09%–
 Download
Other shareholders
ONCOGENEX PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
Virtu KCG Holdings LLC 86,824$31,0000.00%
PRICE T ROWE ASSOCIATES INC /MD/ 46,100$17,0000.00%
DEUTSCHE BANK AG\ 1,405$00.00%
CITIGROUP INC 9,751$4,0000.00%
GOLDMAN SACHS GROUP INC 17,281$6,0000.00%
MORGAN STANLEY 4,250$2,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 48,944$18,0000.00%
BlackRock Inc. 927,688$334,0000.00%
PRELUDE CAPITAL MANAGEMENT, LLC 6,600$2,0000.00%
Bank of New York Mellon Corp 62,846$22,0000.00%
View complete list of ONCOGENEX PHARMACEUTICALS IN shareholders